Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lidocaine 40mg/2ml (2%) inj Mini-Plasco ampoules
1502010J0BNADBE
|
Mini-Plasco lidocaine hydrochloride | Lidocaine hydrochloride | Anaesthesia | No data available |
|
Lidocaine 40mg/2ml (2%) inj Sure-Amp ampoules
1502010J0BLAABE
|
Sure-Amp Lidocaine hydrochloride | Lidocaine hydrochloride | Anaesthesia | No data available |
|
Lidocaine 42mg/ml intrauterine gel
1502010J0AAEUEU
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | No data available |
|
Lidocaine 70mg / Tetracaine 70mg cream
1502010Y0AAABAB
|
Lidocaine/tetracaine | Lidocaine and tetracaine | Anaesthesia | No data available |
|
Lidocaine 70mg / Tetracaine 70mg medicated plasters
1502010Y0AAAAAA
|
Lidocaine/tetracaine | Lidocaine and tetracaine | Anaesthesia | No data available |
|
Lidocaine hydrochlor 0.6%/Cetylpyr chlor 0.02% gel SF
1502010J0AAEKEK
|
Lidocaine hydrochloride (Local Anaesthesia) | Lidocaine hydrochloride | Anaesthesia | No data available |
|
Lidoderm 5% patches
1502010I0BEAAAG
|
Lidoderm | Lidocaine | Anaesthesia | No data available |
|
Lignostab-A 2% 1 in 80,000 injection 2.2ml cartridges
1502010J0BCAECQ
|
Lignostab-A | Lidocaine hydrochloride | Anaesthesia | No data available |
|
LMX 4 cream with Tegaderm dressing 10cm x 6cm
1502010I0BGABAK
|
LMX | Lidocaine | Anaesthesia | No data available |
|
Marcain 0.25% with Adrenaline 50microg/10ml inj amp
1502010C0BBAFAI
|
Marcain | Bupivacaine hydrochloride | Anaesthesia | No data available |
|
Marcain 0.5% with Adrenaline 50microg/10ml inj amp
1502010C0BBAGAJ
|
Marcain | Bupivacaine hydrochloride | Anaesthesia | No data available |
|
Midazolam 100mg/50ml solution for infusion vials
1501041T0AAARAR
|
Midazolam hydrochloride | Midazolam hydrochloride | Anaesthesia | No data available |
|
Mivacron 10mg/5ml solution for injection ampoules
1501050K0BBAAAA
|
Mivacron | Mivacurium chloride | Anaesthesia | No data available |
|
Mivacron 20mg/10ml solution for injection ampoules
1501050K0BBABAB
|
Mivacron | Mivacurium chloride | Anaesthesia | No data available |
|
Mivacurium chloride 10mg/5ml solution for injection ampoules
1501050K0AAAAAA
|
Mivacurium chloride | Mivacurium chloride | Anaesthesia | No data available |
|
Mivacurium chloride 20mg/10ml inj ampoules
1501050K0AAABAB
|
Mivacurium chloride | Mivacurium chloride | Anaesthesia | No data available |
|
Naloxone 40micrograms/2ml solution for injection ampoules
1501070G0AAAAAA
|
Naloxone hydrochloride (Anaesthesia) | Naloxone hydrochloride | Anaesthesia | No data available |
|
Narcan Neonatal 40micrograms/2ml inj ampoules
1501070G0BBAAAA
|
Narcan Neonatal | Naloxone hydrochloride | Anaesthesia | No data available |
|
Naropin 100mg/10ml solution for injection ampoules
1502010R0BBADAE
|
Naropin | Ropivacaine hydrochloride | Anaesthesia | No data available |
|
Naropin 200mg/100ml infusion Polybags
1502010R0BBAEAF
|
Naropin | Ropivacaine hydrochloride | Anaesthesia | No data available |
|
Naropin 20mg/10ml solution for injection ampoules
1502010R0BBAAAA
|
Naropin | Ropivacaine hydrochloride | Anaesthesia | No data available |
|
Naropin 400mg/200ml infusion Polybags
1502010R0BBACAD
|
Naropin | Ropivacaine hydrochloride | Anaesthesia | No data available |
|
Naropin 75mg/10ml solution for injection ampoules
1502010R0BBABAB
|
Naropin | Ropivacaine hydrochloride | Anaesthesia | No data available |
|
Neostigmine 2.5mg/Glycopyrronium brom 500microg/1ml inj amp
1501060N0AAAAAA
|
Neostigmine/ glycopyrronium bromide | Neostigmine metilsulfate | Anaesthesia | No data available |
|
Nimbex 10mg/5ml solution for injection ampoules
1501050W0BBABAB
|
Nimbex | Cisatracurium | Anaesthesia | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.